ANEBULO PHARMAC INC ANEB

$0.32 +6.67% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-02-12 View →
8-K 8-K 2026-02-12 View →
8-K 8-K 2026-02-06 View →
8-K 8-K 2026-01-29 View →
8-K 8-K 2026-01-27 View →
8-K 8-K 2025-12-22 View →
10-Q 10-Q 2025-11-13 View →
8-K 8-K 2025-11-13 View →
10-K 10-K 2025-09-29 View →
8-K 8-K 2025-09-29 View →
8-K 8-K 2025-09-12 View →
8-K 8-K 2025-07-23 View →
10-Q FORM 10-Q 2025-05-13 View →
8-K 8-K 2025-05-13 View →
8-K Current report (material event) 2025-04-15 View →
8-K Current report (material event) 2025-04-14 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
4 Insider transaction 2025-04-07 View →
8-K Current report (material event) 2025-04-07 View →
DEF 14A Proxy statement 2025-03-06 View →
424B5 Prospectus supplement 2025-03-03 View →
8-K Current report (material event) 2025-02-24 View →
S-3 Shelf registration 2025-02-20 View →
10-Q Quarterly report 2025-02-14 View →
8-K Current report (material event) 2025-02-14 View →
8-K Current report (material event) 2025-02-12 View →
4 Insider transaction 2024-12-26 View →
8-K Current report (material event) 2024-12-23 View →
4 Insider transaction 2024-12-10 View →
10-Q Quarterly report 2024-11-13 View →
8-K Current report (material event) 2024-11-13 View →
8-K Current report (material event) 2024-10-17 View →
10-K Annual report 2024-09-25 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.32
Market Cap
52-Week Range
$0.00 $3.42
Average Volume
381 shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.